01
What is a
liquid biopsy?
Liquid biopsy is a technology for predicting disease by detecting or analyzing the concentration of disease-related biomarkers present in samples such as blood, urine, and saliva. Liquid Biopsy, a non-invasive alternative to tissue biopsy, can help determine cancer treatments by identifying clinically relevant biomarkers. Representative circulating biomarkers used in liquid biopsy include circulating tumor cells (CTCs), exosomes, and circulating tumor DNA (CtDNA).
